EU proposing amendment to the Annex XVII to Regulation (EC) No 1907/2006 REACH regarding 1-methyl-2-pyrrolidone European Commission has proposed amendment relates to a new entry in Annex XVII to Regulation (EC) No 1907/2006. It would prohibit the placing on the market of 1-methyl-2-pyrrolidone (NMP) unless: • the registration dossiers are updated with the new Derived No Effect Levels (DNELs) for inhalation and dermal exposure indicated in the proposal, which effectively set occupational exposure limits, and • manufacturers and downstream users comply with those values in the workplace. A general deferral of application of the restriction of 2 years is proposed to allow stakeholders to take the necessary compliance measures. For the wire-coating industry, which would need to replace part of its older production lines prematurely to comply with the new DNELs, a longer specific deferral of 6 years is proposed. Products covered : 1-methyl-2-pyrrolidone (NMP) manufactured, placed on the market or used as a substance on its own or in mixtures in a concentration equal to or greater than 0,3%. Proposed date of adoption: First half of 2018. Proposed date of entry into force: 20 days from publication in the Official Journal of the EU. Final date for comments: 60 days from notification | 
.gif)
